Wellspring Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Sell
1,951
-911
-32% -$437K 0.06% 101
2026
Q1
$1.41M Buy
2,862
+732
+34% +$397K 0.11% 78
2025
Q4
$1.23M Buy
2,130
+1,684
+378% +$952K 0.1% 72
2025
Q3
$216K Sell
446
-145
-25% -$67.5K 0.02% 153
2025
Q2
$240K Sell
591
-48
-8% -$20.1K 0.02% 137
2025
Q1
$318K Buy
639
+4
+0.6% +$2.17K 0.04% 95
2024
Q4
$330K Sell
635
-46
-7% -$25.3K 0.03% 94
2024
Q3
$421K Buy
681
+206
+43% +$122K 0.05% 92
2024
Q2
$263K Buy
475
+95
+25% +$54.4K 0.04% 114
2024
Q1
$221K Buy
+380
New +$213K 0.03% 121

Other funds holding TMO

Wellspring Financial Advisors's TMO Position: Q2 2026 in Review

Wellspring Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 32% in Q2 2026, selling an estimated $437K and leaving 1,951 shares worth $978K. The position accounts for 0.06% of the portfolio, ranked #101.

Wellspring Financial Advisors first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.41M in Q1 2026. 807 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wellspring Financial Advisors held 1,951 shares of Thermo Fisher Scientific worth $978K as of Q2 2026.
  • Wellspring Financial Advisors sold 911 Thermo Fisher Scientific shares in Q2 2026, an estimated $437K.
  • Thermo Fisher Scientific made up 0.06% of Wellspring Financial Advisors's portfolio in Q2 2026, its #101 holding.
  • Wellspring Financial Advisors first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • Wellspring Financial Advisors's Thermo Fisher Scientific position peaked at $1.41M in Q1 2026.
  • 807 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wellspring Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.